Related Experiment Video
Updated: Feb 1, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
Microfluidic techniques for tumor cell detection.
Feifei Tan1, Tianbao Wang1, Haishi Wang1
1College of Communication Engineering, Chengdu University of Information Technology, Chengdu, Sichuan, P. R. China.
Microfluidic devices offer promising early cancer detection by isolating tumor cells from blood. This review explores various microfluidic methods, both active and passive, for improved cancer diagnosis and treatment.
Area of Science:
- Biomedical Engineering
- Oncology
- Analytical Chemistry
Background:
- Cancer metastasis is a primary cause of cancer-related mortality.
- Early detection of circulating tumor cells (CTCs) in peripheral blood is crucial for timely cancer diagnosis and effective treatment.
- Microfluidic technologies have emerged as powerful tools for CTC isolation and detection over the past two decades.
Purpose of the Study:
- To review and analyze microfluidic techniques for tumor cell detection in blood.
- To categorize microfluidic methods into active (requiring external force fields) and passive (without external force fields) approaches.
- To provide a comprehensive overview of the working principles, experimental results, and research characteristics of various microfluidic detection strategies.
Main Methods:
- Review of microfluidic techniques for tumor cell detection based on diverse physical principles.
- Categorization of methods into active (e.g., optical tweezer, electric field, magnetic field, acoustophoresis) and passive approaches.
- Detailed explanation of working principles and analysis of experimental data for each method.
Main Results:
- Microfluidics demonstrates significant potential for isolating and detecting tumor cells from blood samples.
- Both active and passive microfluidic methods offer distinct advantages for tumor cell analysis.
- A comprehensive understanding of different microfluidic strategies aids in selecting optimal approaches for early cancer detection.
Conclusions:
- Microfluidic technologies are vital for advancing early cancer detection through the isolation and analysis of circulating tumor cells.
- The choice between active and passive microfluidic methods depends on specific detection requirements and available resources.
- Continued research in microfluidics promises to enhance the sensitivity and specificity of tumor cell detection, leading to improved patient outcomes.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Detection of Gross Error: The Q Test
Detection of Black Holes
Their closest cousins are neutron stars, which are composed almost entirely of neutrons packed against each other, making them extremely dense. A neutron star has the same mass as the Sun but its diameter is only a few kilometers. Therefore, the escape velocity from their surface is close to the speed of light.
Not until the 1960s, when the first neutron...

